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Objectives. To assess the outcome of fetuses with isolated short femur detected at 19–41 weeks and determine to what extent this
incidental ﬁnding should be a cause of concern in fetuses with a normal previous follow-up. Methods. 156 fetuses with isolated
short femur were compared with a control group of 637 fetuses with normal femur length. FL values were converted into Z-scores
and classiﬁed into 4 groups: control group: Z-score over −2, group 1: Z-score between −2a n d−3, group 2: Z-score between
−3a n d−4, and group 3: Z-score below −4. FL values were plotted with the curves representing Z-scores −2, −3, and −4. To
assess fetal outcome, the frequency of SGA, IUGR, abnormal umbilical Doppler (AUD), Down’s syndrome, and skeletal dysplasia
was determined for each group after delivery, and the relative risk in comparison with the control group was obtained. Finally,
ROC curves were drawn in order to evaluate the FL diagnostic ability for the conditions appearing with increased frequency.
Results. SGA, IUGR, and AUD were more frequent in the fetuses with short femur. Conversely, none of them presented Down’s
syndrome or skeletal dysplasia. According to ROC analysis, FL measurement behaved as a good diagnostic test for SGA and IUGR.
Conclusions. A short femur diagnosis in a fetus with an otherwise normal follow-up determines just a higher risk of being small
(SGA or IUGR).
1.Introduction
Diagnosis of isolated femoral shortening during the second
half of pregnancy has so far been considered a cause for
concern as it has been related with Down’s syndrome (DS)
or skeletal dysplasia (SKD). Although DS can be easily ruled
out with amniocentesis, the indication of this technique
remains unclear as the procedure risk may overcome in this
circumstance the incidence of the disease. Also, knowing if a
short femur is the ﬁrst clue of an SKD is cumbersome, unless
pregnancy advances and shortening worsens or any of the
accompanyingsignsispresent.Inacompleteabsenceofthese
signs,manyoftheSKDsarediagnosedafterdelivery.Theaim
of this study was therefore to assess the outcome of fetuses
with diagnosis of isolated short femur during the second
half of pregnancy and determine to what extent anxiety
is justiﬁed in a low-risk fetal population with uneventful
pregnancy controls.
2. Patients andMethods
We retrospectively studied 156 fetuses with sonographic
diagnosis of isolated short femur (FL Z-score below −2
and absence of other morphological anomalies) performed
between 19 and 41 weeks of gestation and compared them
with a control group of 637 normal fetuses (FL Z-score
over −2). To avoid biases only one examination per fetus
was included in the study and conclusions were based only
on relative risks (RRs) with the control group. All fetuses
presented an accurate gestational age according to a ﬁrst
trimester crown rump length and underwent a normal and
uneventful pregnancy follow-up, including a ﬁrst trimester
DS screening with a combined method (nuchal translucency,
β-HCG, and PAPP-A) and a midpregnancy anomaly scan.
Fetalexaminationincludedacompletebiometry(BPD,OFD,
HC, AC, and FL) and a Doppler assessment of the umbilical
artery resistance index.2 ISRN Obstetrics and Gynecology
To avoid gestational inﬂuences and make comparisons
feasible, FL values were also converted into Z-scores accord-
ing to the following formula: Z-score = (value − mean
value)/SD and were posteriorly classiﬁed in 4 groups: control
group (n = 637) included fetuses with Z-score over −2,
group 1 (n = 114) included fetuses with Z-score between
−2a n d−3, group 2 (n = 27) included fetuses with Z-score
between −3a n d−4, and ﬁnally group 3 (n = 15) included
fetuses with Z-score below −4. Raw FL values were after-
wards grouped and plotted in a scattergram according to the
previous classiﬁcation, along with three curves representing
Z-scores −2, −3, and −4.
For the 4 groups described, the frequency of small
for gestational age (SGA), intrauterine growth retardation
(IUGR), abnormal umbilical Doppler (AUD), DS, and SKD
was calculated. SGA and IUGR were considered when the
BW was respectively below the 10th and 5th percentile of
published BW nomograms [1], and an AUD was diagnosed
when the umbilical artery resistance index was over the 95th
percentileofpublished Doppler nomograms [2]. Ultrasound
examinations were all performed by the ﬁrst author with
two colour Doppler equipments: a Medison Sonoace 8000
ultrasound machine with a 3–7MHz convex probe and
a Toshiba SSH 140 ultrasound machine with a 3,5MHz
convex probe. Frequencies of SGA, IUGR, AUD, DS, and
SKD were compared in order to determine if diﬀerences
betweengroupswerestatisticallysigniﬁcantandrelativerisks
(RRs) were calculated with the formula RR = studied group
frequency/control group frequency.
Finally, receiver-operating characteristic (ROC) curves
were drawn calculating the P and the area under the curve
(AUC) in order to evaluate the FL diagnostic ability for
the diseases appearing with increased frequency. To avoid
gestational inﬂuence, curves analyzed only FL Z-Scores.
Statistical analysis and charts were performed with the
software GraphPad Prism 5a, for Apple Macintosh (Graph-
Pad Software Inc, San Diego, CA, USA). Signiﬁcance was
determined using the chi-square test, with a threshold estab-
lished at P<0.05 (signiﬁcant) and P<0.001 (highly signiﬁ-
cant).
3. Results
Results are shown in Figures 1 and 2 and in Table 1.
Figure 1 depicts the scattered values of the 793 FL values,
grouped according to the classiﬁcation earlier described. 637
fetuses (roundels) had a normal FL (Z-score over −2), 114
fetuses (squares) had a Z-score between −2a n d−3, 27
fetuses (clear triangles) had a Z-score between −3a n d−4,
and ﬁnally 15 fetuses (dark triangles) had a Z-score below
−4.
Table 1 shows the distribution frequency and relative
risks (RRs) for SGA, IUGR, AUD, DS, and SKD according
to the classiﬁcation in groups described. In the control group
(n = 637), 122 fetuses (19.1%) were SGA, 63 (9.9%) were
IUGR, and 49 (7.7%) had AUD. In group 1 (n = 114), 44
fetuses (38.6%) were SGA, 30 (26.3%) were IUGR, and 17
(14.9%) had AUD. In group 2 (n = 27), 11 fetuses (40.7%)
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Figure 1: Scattergram of FL values depicted according to the Z-
score classiﬁcation. Roundels: fetuses with FL Z-score over −2,
squares:fetuseswithFLZ-scorebetween −2and−3,cleartriangles:
fetuses with FL Z-score between −3a n d−4, and dark triangles:
fetuses with FL Z-score below −4. Curves represent Z-scores −2,
−3, and −4.
were SGA, 7 (25.9%) were IUGR, and 7 (25.9%) had AUD.
Finally, in group 3 (n = 15), 6 fetuses (40.7%) were SGA, 5
(33.3%) were IUGR, and 5 (33.3%) had AUD. No fetuses in
group 1, 2, or 3 had a neonatal diagnosis of SKD or DS.
Relative risks for group 1 fetuses were 2 for SGA, 2.6 for
IUGR, and 1.9 for AUD. Relative risks for group 2 fetuses
were 2.1 for SGA, 2.6 for IUGR, and 3.4 for AUD. Finally,
relative risks for group 3 fetuses were 2.1 for SGA, 3.4 for
IUGR, and 4.3 for AUD. As no fetus was diagnosed of DS
or SKD in any of the 3 groups studied, relative risk for
these anomalies was considered to be similar to the general
population.
Figure 2showstheROCcurvesandareasunderthecurve
(AUC) for the conditions that appeared with increase of
frequency. As only SGA, IUGR, and AUD were found to be
associatedwithFLshortening,onlythesecurvesaredepicted.
To avoid gestational inﬂuences, curves analyze only FL Z-
scores. According to this analysis, the diagnostic ability of FL
measurementforSGAandIUGRwashigh(AUC=0.726,P<
0.0001, and AUC = 0.726, P<0.0001), and the diagnostic
ability of FL measurement for AUD was moderate (AUC =
0.635, P<0.0001). The best predictor value for both SGA
and IUGR was a LF Z-score of −1.03 with a sensitivity of
66% and a speciﬁcity of 67%.ISRN Obstetrics and Gynecology 3
Table 1: Outcome of fetuses and relative risk according to the femur length Z-score.
N >2 SD (Control)
637
(Group 1)
114
(Group 2)
27
(Group 3)
15
Outcome
SGA (183)
IUGR (105)
AUD (78)
122 (19.1%)
63 (9.9%)
49 (7.7%)
44 (38.6%)
30 (26.3%)
17 (14.9%)
11 (40.7%)
7 (25.9%)
7 (25.9%)
6 (40.0%)
5 (33.3%)
5 (33.3%)
Relative risk
SGA
IUGR
AUD
RR = 1
RR = 1
RR = 1
RR = 2.0
RR = 2.6
RR = 1.9
RR = 2.1
RR = 2.6
RR = 3.4
RR = 2.1
RR = 3.4
RR = 4.3
SGA: small for gestational age, IUGR: intrauterine growth restriction, AUD: abnormal umbilical Doppler, DS: Down’s syndrome, SKD: skeletal dysplasia, and
SD: standard deviation.Number of fetuses with DS or SKD in any group was 0. Relative risk close to 1.
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Figure 2: Receiver-operating characteristic (ROC) curves repre-
senting the diagnostic ability of the FL Z-score for the diagnosis of
thethreeconditionsassociatedwithfemurshortening(SGA,IUGR,
and AUD). AUC: area under the curve.
4. Discussion
A short femur diagnosed in a fetus with normal previous
follow-up has represented a cause of concern as it has
been related with DS or SKD, serious conditions that cause
intrauterine death or severe handicap. In order to clarify
if this concern was justiﬁed when a short FL was the only
ﬁnding, we reviewed the published scientiﬁc references and
analyzed our own database.
Concerning DS, scientiﬁc evidence reveals that FL short-
ening or FL/AC ratio are in fact very soft markers of DS
with very low predictive value [3, 4]. Therefore, taking
into account the invasive procedure risk, an isolated FL
shortening should not be considered an indication for fetal
karyotype. On the other hand, SKDs are a wide spectrum of
diseases characterized by long bone shortening, sonograph-
ically more evident at the femur [5], which tend to show
multiple morphological anomalies. SKDs were initially clas-
siﬁed according to radiological descriptions. Currently, with
the introduction of molecular diagnosis, it has been shown
that many of the SKDs derive from mutations within the
same gene involved and are therefore considered phenotypic
variations of the same disease [6]. The three most common
prenatal-onset skeletal dysplasias are osteogenesis imperfecta
type 2, thanatophoric displasia, and achondrogenesis type
2, accounting for almost 40% of the cases [7]. As many of
theseprenataldisordersarelethalconditions,achondroplasia
becomes postnatally the most frequent human dwarﬁsm [8].
Published series have shown that SKDs rarely present
isolated bone shortening because they are always accom-
panied by a wide variety of ultrasonographic signs [8, 9].
Therefore, it is important to underline that a fetus with
isolated FL shortening will probably not suﬀer from any
type of SKD. The most important accompanying sign of
SKDs is the curved femur that appears in more than 40
diﬀerent conditions [10]. Other signs are the narrow thorax
combined with a protuberant abdomen and the anomalies
of the skull. Unfortunately these signs are unspeciﬁc for the
distinct disorders so a precise diagnosis is not always possible
[11]. Although the existence of accompanying sonographic
signsisalwaystheruleevenincasesofextremelyrarediseases
[12], in a few cases we may ﬁnd only an isolated short femur.
These cases probably represent either benign familiar femur
shortening or unilateral isolated femoral hypoplasias, both
conditions with good prognosis [13, 14].
Concerningourdata,wedidnotﬁndfetuseswithSKDor
DSinanyoftheanalyzedgroups,evenincaseswithFLbelow
Z-score −4. Conversely SGA was the most frequent anomaly
associated with femur shortening, followed by IUGR: 61
fetuses (39%) were SGA (RR = 2.0) and 42 (27%) were
IUGR (RR = 2.7). Also 29 fetuses (18%) had an AUD (RR =
2.3). These frequencies were at least 2 times higher than4 ISRN Obstetrics and Gynecology
the SGA/IUGR/AUD frequencies in the control group (P<
0.001).
We were aware that the frequency of SGA/IUGR/AUD in
the control group was also slightly increased, but this could
be explained by the high proportion of low class pregnant
women attending our clinics. As this circumstance was the
same for all the groups studied, we avoided biases taking
intoaccountonlytheRRwiththecontrolgroup.Concerning
this RR, we found that a similar result had been reached by
Weisz et al. who found that the odds ratio (RR) for SGA in
cases of isolated short femur was 3 [15]. In another study
Papageorghiou et al. studied 83 cases with isolated femur
shortening and showed there were not cases of chromosomal
abnormalities or SKD. Conversely early severe IUGR with
abnormal umbilical artery Doppler ﬁndings and delivery
before 37 weeks occurred in 33/83 (40%) cases. These
pregnancies also had high rates of pre-eclampsia (36%) and
intrauterine death (33%) [16]. Our results, however, are not
inagreementwiththeonesofTodrosetal.,whofoundahuge
proportion of fetal pathology, including DS and SKD. We
were surprised of such incidence, which might be attributed
to a selection bias as they were surely studying a selected
sample, very diﬀerent from ours [17].
Femurshorteninghasbeendeﬁnedbydiﬀerentclinicians
according to diﬀerent thresholds and criteria [11, 16–20].
The most important being the FL/AC ratio below 0.16–0.18,
the 10th, 5th, and 3th percentiles and the −3a n d−4S D .
However, we consider our results had been the same using
any of them as all reﬂect the same pathological condition.
According to our data, fetuses with incidental diagnosis of
short femur during the second half of pregnancy, who had
undergone a normal pregnancy control, are at risk of being
small fetuses (SGA/IUGR) with or without AUD (RR = 2-3).
A FL cut-oﬀ value of −1 SD allows to detect 66% of small
fetuses (SGA and IUGR) with a speciﬁcity of 67%.
In summary, the diagnosis of an isolated short femur
at 19–41 weeks of pregnancy determines just a higher risk
of being small. Concerns about the existence of DS or SKD
should be moderated.
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